A novel prostate cancer immunotherapy using prostate-specific antigen peptides and Candida skin test reagent as an adjuvant

OBJECTIVES: Our group developed the use of the Candida skin test reagent as an adjuvant of cell-mediated immunity in designing a human papillomavirus therapeutic vaccine. Here, this technology is being applied for designing a prostate cancer immunotherapy. METHODS: Peptides based on the prostate-spe...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdallah, Al-Ola, Coleman, Hannah, Kamel, Mohamed, Davis, Rodney, Landrum, Teri, Spencer, Horace, Mackintosh, Sam, Mahmoud, Fade A, Milojkovic, Natasa, Wicker, Chester, Arnaoutakis, Konstantinos, Nakagawa, Mayumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144584/
https://www.ncbi.nlm.nih.gov/pubmed/30245818
http://dx.doi.org/10.1177/2050312118800202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144584/
https://www.ncbi.nlm.nih.gov/pubmed/30245818
http://dx.doi.org/10.1177/2050312118800202

Ejemplares similares